Ragosa Mark (CIK 0001835458)

Latest company ownership

Shares held
19,900
Last filed at
Nov 14, 2025
Confidence Score
0.0
2025Q4
Confidence Score History
2020Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 8, 2025 Dec 10, 2025 Kiniksa Pharmaceuticals International, plc CFO Sell 5.0 -42,841 -57.95% ✓ $1.8M
Nov 12, 2025 Nov 14, 2025 Kiniksa Pharmaceuticals International, plc CFO Sell 7.5 -19,900 -39.03% ✓ $814.7K
Oct 28, 2025 Oct 30, 2025 Kiniksa Pharmaceuticals International, plc CFO Sell 53.8 -100 -0.32% ✓ $4.1K
Sep 1, 2025 Sep 3, 2025 Kiniksa Pharmaceuticals International, plc CFO Sell 22.5 -3,820 -5.87% ✗ $128.6K
Aug 4, 2025 Aug 6, 2025 Kiniksa Pharmaceuticals International, plc CFO Sell 7.5 -18,889 -41.15% ✓ $621.3K
Jun 3, 2025 Jun 5, 2025 Kiniksa Pharmaceuticals International, plc CFO Sell 7.5 -18,299 -40.39% ✓ $527K
Apr 29, 2025 May 1, 2025 Kiniksa Pharmaceuticals International, plc CFO Sell 5.0 -88,395 -52.17% ✓ $2.3M
Apr 26, 2025 Apr 29, 2025 Kiniksa Pharmaceuticals International, plc CFO Sell 26.3 -479 -1.74% ✗ $10.2K
Apr 7, 2025 Apr 9, 2025 Kiniksa Pharmaceuticals International, plc CFO Sell 26.3 -1,303 -4.69% ✗ $26.4K
Apr 1, 2025 Apr 3, 2025 Kiniksa Pharmaceuticals International, plc CFO Sell 26.3 -1,617 -6.05% ✗ $35.2K
Mar 20, 2025 Mar 24, 2025 Kiniksa Pharmaceuticals International, plc CFO Sell 7.5 -15,944 -40.54% ✓ $368.5K
Mar 16, 2025 Mar 19, 2025 Kiniksa Pharmaceuticals International, plc CFO Sell 12.5 -20,791 -22.86% ✓ $480.1K
Mar 12, 2025 Mar 14, 2025 Kiniksa Pharmaceuticals International, plc CFO Sell 7.5 -36,372 -61.30% ✓ $809.3K
Dec 6, 2024 Dec 10, 2024 Kiniksa Pharmaceuticals International, plc CFO Sell 7.5 -27,829 -37.74% ✓ $594K
Dec 3, 2024 Dec 5, 2024 Kiniksa Pharmaceuticals International, plc CFO Sell 17.5 -15,116 -18.00% ✓ $323K
Sep 1, 2024 Sep 4, 2024 Kiniksa Pharmaceuticals International, plc CFO Sell 22.5 -3,216 -6.67% ✗ $86K
Jul 23, 2024 Jul 25, 2024 Kiniksa Pharmaceuticals International, plc CFO Sell 7.5 -24,248 -55.74% ✓ $601.1K
Apr 26, 2024 Apr 30, 2024 Kiniksa Pharmaceuticals International, plc CFO Sell 27.5 -509 -2.58% ✗ $9.1K
Apr 8, 2024 Apr 8, 2024 Kiniksa Pharmaceuticals International, plc CFO Sell 26.3 -791 -4.04% ✗ $14.2K
Apr 1, 2024 Apr 3, 2024 Kiniksa Pharmaceuticals International, plc CFO Sell 26.3 -514 -2.96% ✗ $10.1K
Jan 3, 2024 Jan 4, 2024 Kiniksa Pharmaceuticals International, plc CFO Sell 10.0 -12,000 -43.43% ✓ $240K
Sep 1, 2023 Sep 6, 2023 Kiniksa Pharmaceuticals International, plc CFO Sell 26.3 -1,338 -4.28% ✗ $23.8K
Apr 26, 2023 Apr 28, 2023 Kiniksa Pharmaceuticals International, plc CFO Sell 27.5 -291 -2.29% ✗ $3.2K
Apr 10, 2023 Apr 11, 2023 Kiniksa Pharmaceuticals International, plc CFO Sell 27.5 -791 -6.32% ✗ $8.5K
Mar 16, 2023 Mar 20, 2023 Kiniksa Pharmaceuticals International, plc CFO Sell 27.5 -890 -4.69% ✗ $10K
Sep 2, 2022 Sep 6, 2022 Kiniksa Pharmaceuticals International, plc CFO Sell 27.5 -547 -6.66% ✗ $6.3K
Apr 26, 2022 Apr 28, 2022 Kiniksa Pharmaceuticals International, plc CFO Sell 27.5 -282 -4.25% ✗ $2.8K
Mar 21, 2022 Mar 23, 2022 Kiniksa Pharmaceuticals International, plc CFO Sell 26.3 -1,047 -15.64% ✗ $11.5K
Mar 16, 2022 Mar 18, 2022 Kiniksa Pharmaceuticals International, plc CFO Sell 27.5 -303 -7.61% ✗ $3.1K
Dec 31, 2020 Jan 5, 2021 Kiniksa Pharmaceuticals International, plc CFO Sell 26.3 -1,297 -29.45% ✗ $22.9K